Systemic Therapy and Surgical Management of Peritoneal Mesothelioma.

Malignant peritoneal mesothelioma is an aggressive and rare disease that affects the serosal membranes. The outcomes of patients who suffer from this disease have improved because of the advances in imaging, genetics, and treatment strategies such as systemic therapy and cytoreduction surgery and hyperthermic intraperitoneal chemotherapy. Multidisciplinary care remains essential for enhancing survival and quality of life.